Recent Headlines
GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM
The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.
ALPCO Diagnostics Recognized for Support of the American Red Cross 2011 Relief Efforts
ALPCO was recognized on May 29, 2012 for their generous contributions to the American Red Cross in 2011. - June 11, 2012 - ALPCO
SFL’s Senior Communication Manager to Speak at the 8th Annual Conference of the Pharmaceutical Contract Management Group
SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled “The Regulatory Framework for New Drug Innovation” at the 8th Annual Conference of the Pharmaceutical Contract Management Group. - June 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012 - ALPCO
Rocky Mountain Fertility Center Offers New Package Prices on Tubal Reversals
Rocky Mountain Fertility Center has released new lower package prices on tubal reversals. The infertility center has been devoted to assisting couples achieve success and has announced a new lower fallopian tubal reversal procedure (tubal re-anastomosis) price in conjunction with Crown Point... - March 15, 2012 - Rocky Mountain Fertility
Rocky Mountain Fertility Center Invites Patients to Participate in Study on Egg Freezing
Rocky Mountain Fertility Center has just announced they are taking new eligible patients to participate in a research study on egg freezing. The study offers participants a significantly reduced cost to for an IVF cycle for participation in the oocyte freezing study. Your participation in this... - March 15, 2012 - Rocky Mountain Fertility
Patients Have Once Again Recognized Rocky Mountain Fertility Center’s, Dr. Deborah Smith as One of America's Most Compassionate Doctors
Patients have once again recognized Rocky Mountain Fertility Center’s, Dr. Deborah Smith as one of America's Most Compassionate Doctors and have voted her a coveted Patients' Choice Award as one of Colorado’s Favorite Doctors. The Compassionate Doctor Certification is part of the... - March 15, 2012 - Rocky Mountain Fertility
Rocky Mountain Fertility Center Announces That Nutrition Counseling is Now Available Onsite
Rocky Mountain Fertility Center has just announced that they are now offering nutrition counseling onsite for a well rounded approach to wellbeing and fertility management. This program is part of the infertility clinic’s “healthy mind and body” approach which encourages patients... - March 01, 2012 - Rocky Mountain Fertility
Rocky Mountain Fertility Center is Making Donor Oocyte Cycles More Affordable
Rocky Mountain Fertility Center has just announced that they are offering a new infertility treatment package for patients that need donor oocytes in order to conceive. This new package will significantly decrease the cost of a donor oocyte treatment cycle. Because Donor oocyte IVF cycles are so... - February 29, 2012 - Rocky Mountain Fertility
Rocky Mountain Fertility Center Offers New Package Prices on Fertility Therapy
Rocky Mountain Fertility Center has released new lower package prices on fertility therapy. The infertility center has been devoted to assisting couples and individuals achieve success with their fertility treatment and helping patients afford their fertility therapy. Rocky Mountain Fertility... - February 26, 2012 - Rocky Mountain Fertility
Bionostics Sponsors MassBio’s Massachusetts CRO/CMO Symposium
Bionostics, a worldwide leader in proprietary calibrator, quality control, and cGMP reagent final fill and finish to the diagnostics and medical device industries, today announced its major sponsorship of the inaugural one-day Massachusetts Biotechnology Council (MassBio) CRO/CMO Symposium. - February 23, 2012 - Bionostics
Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012 - ALPCO
SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event
SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd
GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011
GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.
GenScript Launches Rush Gene Synthesis Service
Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in the global market. - December 27, 2011 - GenScript USA Inc.
GenScript Sponsors 2011 iGEM Undergraduate Synthetic Biology Competition
Internationally recognized biology contract research organization GenScript USA Inc. congratulates the achievements of eight teams they sponsored in 2011 iGEM undergraduate synthetic biology competition. The iGEM teams have utilized GenScript’s gene synthesis service to build novel... - December 17, 2011 - GenScript USA Inc.
SFL’s Public Affairs Now Covers Bioethics
SFL’s Public Affairs team, helping organizations shape EU rules, saw exciting expansion in 2011. - December 11, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
SFL Thanks Clients and Partners for Successful Collaborations
With the end of 2011 approaching, SFL can reflect on a very successful year of extension and expansion in all areas. The company’s client base has expanded internationally as demand has grown for its personalized and comprehensive services in the fields of Regulatory Affairs, Public Affairs, Legal Services and Medical Communication. - December 08, 2011 - SFL Regulatory Affairs & Scientific Communication Ltd
Announcing the Release of a Novel Tool for the Assessment of Porcine Islet Functionality: the Mercodia Porcine C-peptide ELISA
Mercodia announced the release of their new Porcine C-Peptide ELISA at the recent Cell Transplant Society (CTS) and International Xenotransplantation Association (IXA) meeting in Miami, Florida, October 23-26. This assay provides the type 1 diabetes, and more specifically the islet transplantation,... - November 10, 2011 - Mercodia Inc.
RayBiotech, Inc. Engages Industry Expert for Business Development & Growth Advisory Services
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities. - November 10, 2011 - RayBiotech, Inc
WILEX Inc. and ALPCO Diagnostics Sign Marketing and Distribution Agreement for North America
WILEX AG announces that its wholly owned US subsidiary WILEX Inc., Cambridge, MA, USA, entered into a exclusive co-marketing and distribution agreement with American Laboratory Products Company Inc., (ALPCO Diagnostics) Salem, NH, USA, for the commercialization of the Serum HER-2/neu ELISA test in North America. - October 10, 2011 - ALPCO
GenScript Launches Animal Model Services Worldwide
Internationally recognized biology contract research organization GenScript USA Inc. today announced that it has launched a broad spectrum of Animal Model Services for researchers to investigate the efficacy and safety profile of drug candidates. The services include in vivo drug efficacy,... - August 10, 2011 - GenScript USA Inc.
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011 - RayBiotech, Inc
ALPCO Appoints CST China as Their Exclusive Distributor in China
ALPCO Diagnostics, a leading manufacturer and distributor of high quality immunoassay kits, is pleased to announce that they have appointed CST (Shanghai) Biological Reagents Company Ltd. (CST China) as their new distributor in China. With CST China as their new distribution channel in China,... - June 23, 2011 - ALPCO
GenScript Launches eStainTM 2.0 Protein Staining System
Internationally recognized Contract Research Organization (CRO) GenScript USA Incorporation has launched eStainTM 2.0 Protein Staining System to replace the original eStainTM System. The eStainTM 2.0 System provides fast and convenient protein gel staining in 7 minutes or less and has improved the... - May 18, 2011 - GenScript USA Inc.
ALPCO Diagnostics' Partnership with Electra-Box Diagnostica AB Looks to the Future of American-Swedish Research Collaborations
It is a long-standing tradition in the scientific research community for researchers to engage in collaborative studies spanning international borders. In keeping with this spirit, and with a desire to foster international collaboration, ALPCO Diagnostics is pleased to announce that they have entered into a distribution agreement with Electra-Box Diagnostica AB of Sweden. - May 13, 2011 - ALPCO
GenScript Continues Deploying New Websites in Europe
GenScript USA Inc. has launched new websites at www.genscript.fr in France and at www.genscript.es in Spain to offer easier access for local French and Spanish searchers. - May 01, 2011 - GenScript USA Inc.
GenScript Will Launch Services with GANP® Technology for World Wide Market Excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP® mice from TransGenic Inc. to produce high-affinity antibodies to scientists. - March 25, 2011 - GenScript USA Inc.
The Patient’s Choice Award Goes to Rocky Mountain Fertility’s Very Own Dr. Deborah Smith
Rocky Mountain Fertility patients recognized Dr. Deborah Smith with a Patient’s Choice Award. Rave reviews and high praise from patient comments on Vitals.com has Dr. Smith considered a top doctor in her field and a patient favorite. “The most important recognition comes from our... - March 18, 2011 - Rocky Mountain Fertility
GenScript Launches New Website in Germany
GenScript USA Inc. has launched a new website at www.genscript.de in Germany to offer easier access for local German searchers. - March 16, 2011 - GenScript USA Inc.
UK Based Diagnostic Company, Randox, Expand Their Portfolio to Meet Demand for Forensic Drug Testing
As drug abuse and drug related crimes continue to prevail, expert forensic analysis is fundamental to the justice process. Global diagnostic company Randox Laboratories has released a number of new products for drug testing in public and private laboratories worldwide. - February 06, 2011 - Randox Laboratories
New Liquid Haptoglobin Assay for the RX Series
The new liquid stable Haptoglobin kit from Randox provides a highly sensitive and specific method for the quantitative determination of Haptoglobin in human serum. The method is fully automated and suitable for use on the RX series of bench top clinical analysers including the RX daytona and RX imola. - January 20, 2011 - Randox Laboratories
GenScript Corporation Has Installed the First BiacoreTM T200 Biosensor in the World
GenScript Corporation and GE Healthcare Life Sciences China together held an opening ceremony on Dec 22nd 2010 in Nanjing China, to celebrate the successful installation of the first unit of BiacoreTM T200 instrument in the world. To an audience of primarily research scientists from both big... - January 19, 2011 - GenScript USA Inc.
ALPCO Appoints Cosmo Bio Co., Ltd. as Their New Distribution Channel in Japan
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - January 10, 2011 - ALPCO
Interest in Sclerostin as a Regulator of Bone Formation Remains High
Sclerostin, a protein produced primarily in osteocytes, inhibits osteoblast activity via antagonism of the wnt signaling pathway and, as such, has garnered a great deal of attention as a potential therapeutic target for increasing bone formation. The annual publication rate for peer-reviewed... - December 07, 2010 - ALPCO
RayBiotech Renews Biomarker Discovery Grants for 2011
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011. RayBiotech will accept applications for pilot grants beginning in early 2011. Winning applicants will be eligible for restricted grants of $5,000 to $20,000 worth of RayBiotech products and/or services. This is the second year RayBiotech has sponsored these grants to demonstrate the application of antibody-based products to biomarker discovery. - December 04, 2010 - RayBiotech, Inc
GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
GenScript received the approval of Animal Welfare Assurance for its animal facility on 9 Nov, 2010. This approval accentuates the responsibilities and procedures of GenScript regarding the care and use of laboratory animals. - November 24, 2010 - GenScript USA Inc.
Immunologix Teams with GenScript to Produce Human Antibody Therapeutics Ready for Clinical Trials
Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening,... - November 11, 2010 - GenScript USA Inc.
RayBiotech Launches Th17 Antibody Arrays for Immune Research
RayBiotech, Inc., the Protein Array Pioneer Company, today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells. Th17 cells have been linked to the immune response to fungal and certain bacterial infections, as well being associated with several autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and multiple sclerosis. - November 03, 2010 - RayBiotech, Inc
RayBiotech Awarded NIH/STTR Grant for Endometriosis Research
RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis. - October 22, 2010 - RayBiotech, Inc
RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform
RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010 - RayBiotech, Inc
Mercodia Will Market Their Oxidized LDL ELISA as an In-vitro Diagnostic for Clinical Use
The United States Food and Drug Administration (FDA) has determined that the Mercodia Oxidized LDL ELISA can be used clinically as an IVD. Oxidized LDL has been shown to play a key role in the initiation and progression of atherosclerosis, making the Mercodia Oxidized LDL ELISA a critical biomarker in cardiovascular disease-related studies and the most widely used method commercially available today. - September 27, 2010 - Mercodia Inc.
GenScript Launches CloneReadyTM Gene Collections
GenScript’s CloneReadyTM Gene Collections provide convenient and cost-effective solutions to researchers’ gene related practices. - September 09, 2010 - GenScript USA Inc.
Accurately and Efficiently Monitor the Performance of HbA1c Assays
The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long term diabetic control than blood glucose. - August 04, 2010 - Randox Laboratories
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Randox Provides the Gold Standard in Renal Damage Testing – Cystatin C
The Predictive Safety Testing Consortium (PSTC) has provided data which supports the use of various renal markers, including Cystatin C, in a preclinical setting. The biomarkers have been shown to outperform traditional markers, such as creatinine and blood urea nitrogen (BUN), in both specificity... - July 16, 2010 - Randox Laboratories
New Range of Lyophilised Controls from Randox
Randox Laboratories is one of the largest manufacturers of quality control sera in the world. The Acusera range of quality controls currently covers over 290 parameters and is set to expand with the introduction of several new quality controls. Quality control from Randox guarantees outstanding... - June 25, 2010 - Randox Laboratories
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO